Patents Assigned to Concordia Pharmaceuticals, Inc.
  • METHODS AND COMPOSITIONS FOR ORAL DELIVERY OF FTS
    Publication number: 20120082722
    Abstract: Disclosed are oral dosage forms containing a Ras antagonist including FTS and structural analogs thereof, and at least one pharmaceutically acceptable excipient other than a cyclodextrin, and methods of orally administering same to treat diseases and disorders responsive to the Ras antagonists.
    Type: Application
    Filed: December 15, 2011
    Publication date: April 5, 2012
    Applicant: CONCORDIA PHARMACEUTICALS, INC.
    Inventor: Victor J. Bauer
  • Methods and compositions for oral delivery of FTS
    Patent number: 8088756
    Abstract: Disclosed are oral dosage forms containing a Ras antagonist including FTS and structural analogs thereof, and at least one pharmaceutically acceptable excipient other than a cyclodextrin, and methods of orally administering same to treat diseases and disorders responsive to the Ras antagonists.
    Type: Grant
    Filed: August 18, 2005
    Date of Patent: January 3, 2012
    Assignee: Concordia Pharmaceuticals, Inc.
    Inventor: Victor J. Bauer
  • ALKOXYALKYL S-PRENYLTHIOSALICYLATES FOR TREATMENT OF CANCER
    Publication number: 20100189781
    Abstract: Disclosed are alkoxyalkyl S-prenylthiosalicylates and pharmaceutical compositions containing the same and a pharmaceutically acceptable carrier. Methods for treating a human afflicted with cancer, including solid tumors, or a hematological malignancy by administering to the human in need thereof an effective amount of an alkoxyalkyl S-prenylthiosalicylate are also disclosed.
    Type: Application
    Filed: January 20, 2010
    Publication date: July 29, 2010
    Applicants: RAMOT AT TEL-AVIV UNIVERSITY LTD., CONCORDIA PHARMACEUTICALS, INC.
    Inventors: Yoel Kloog, Liat Goldberg, Victor J. Bauer
  • Methods and Compositions for Oral Delivery of FTS
    Publication number: 20090226512
    Abstract: Disclosed are oral dosage forms containing a Ras antagonist including FTS and structural analogs thereof, and at least one pharmaceutically acceptable excipient other than a cyclodextrin, and methods of orally administering same to treat diseases and disorders responsive to the Ras antagonists.
    Type: Application
    Filed: August 18, 2005
    Publication date: September 10, 2009
    Applicant: Concordia Pharmaceuticals, Inc.
    Inventor: Victor J. Bauer